| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |